Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...
Cuts to the CDC and FDA, experts say, could reverse hugely successful campaigns to cut cigarette smoking rates and curb teen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback